USNA - NYSE
USANA Health Sciences, Inc.
$17.46
-3.3%USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
At a Glance
Live SnapshotUSANA Health Sciences, Inc. Management Team
Mr. Brent L. Neidig
Chief Commercial Officer
Compensation
$549,188
Mr. Jim Brown
Chief Executive Officer & President
Compensation
$962,089
Mr. G. Douglas Hekking
Chief Financial Officer
Compensation
$610,166
Peter Benedict
Chief Information Officer
Mr. P. Joshua Foukas J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
Compensation
$536,857
Mr. Walter Noot
Chief Operating Officer
Compensation
$612,932
Mr. David Mulham
Chief Sales Officer
Compensation
$601,721
Mr. Patrique Richards
Executive Director of Investor Relations & Business Development
Dr. John Cuomo
Executive Director of Product Development & Technology
Dr. Myron W. Wentz Ph.D.
Founder & Chairman Emeritus
USANA Health Sciences, Inc. Insider Positioning
During the last 12 months, insiders have sold $945K worth of USNA shares, with no buying activity reported.
3 Months
0
0.00
20.5K
386.40K
-386K
-$386K
3-6 Months
0
0.00
12.6K
257.81K
-258K
-$258K
6-9 Months
0
0.00
4.8K
95.76K
-96K
-$96K
9-12 Months
0
0.00
6.7K
205.31K
-205K
-$205K
Top Buyers
No buying activity
Top Sellers
Foukas Joshua
Officer: Chief Legal Officer
$170K
Benedict Peter
Officer: Chief Information Officer
$150K
Jones Paul A.
Officer: Chief People Officer
$129K
Mulham David Mulham
Officer: Chief Sales Officer
$125K
Iiekking G Doug
Officer: Chief Financial Officer
$101K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $945K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
USNA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | January 03, 2026 | 2026 | |
DEF 14A DEF 14A 2024 N/A | April 04, 2025 | December 28, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | March 22, 2024 | December 30, 2023 | 2023 | |
DEF 14A DEF 14A N/A | March 31, 2023 | March 31, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 30, 2022 | May 09, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 30, 2021 | May 10, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 20, 2020 | May 01, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 22, 2019 | May 01, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 23, 2018 | May 02, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 24, 2017 | May 03, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.